Main Menu

News language and date

Analysis over time

Sanofi-Aventis

Information about this organisation was last updated on Thursday, February 9, 2012.

Help about this topicNames

Sanofi-Aventis (Eu,tr)

Sanofi Pasteur (da,tr)

Sanofi Aventis (da,sv)

Sanofi-Pasteur (da,tr)

Sanofi-aventis (da,sl)

Konzern Sanofi-Aventis (de)

Санофи-Авентис (bg,ru)

Sanofi-Aventis-Konzern (de)

Pharmaunternehmens Sanofi-Aventis (de)

赛诺菲－安万特 (zh)

サノフィ・アベンティス (ja)

Help about this topicExternal resources

Photo From Wikipedia

Image obtained automatically
from Wikipedia

Read Wikipedia entry

Help about this topicExplore Relations


EMM Visual Explorer

Help about this topicRelated People

Chris Viehbacher (4)

Christine Lagarde (3)

François Duhen (2)

Xavier de Villepion (2)

Nicolas Sarkozy (2)

Gilbert Tribo (2)

Ben Bernanke (2)

Jacques Servier (2)

François Fillon (2)

Marcus Röske (2)

Leif Vestergaard-Pedersen (2)

Fabian Cancellara (2)

Göran Stiernstedt (2)

Bill Gates (2)

David Cameron (2)

Xavier Bertrand (2)

Julie Skovsby (2)

Natascha Vlahovic (2)

Axel Weber (1)

Isabelle Prévost-Desprez (1)

François Honnorat (1)

Kris Peeters (1)

Abdennour Ali-Yahia (1)

Isabelle Labeyrie (1)

Ali Benhadj (1)

Sidi Abdallah (1)

Georges Chiche (1)

Viktor Yanukovich (1)

Natalia Ligachova (1)

Ihor Shevliakov (1)

Viktoria Siumar (1)

Mikhaïlo Brodsky (1)

Martin Raiser (1)

Muammar Gaddafi (1)

Luc Chatel (1)

Frédéric Lefebvre (1)

Nora Berra (1)

Bruno Le Maire (1)

Noël Ndong (1)

Bauke Mollema (1)

Help about this topicAssociated People

Marcus Röske (0.8)

Gilbert Tribo (0.7)

Chris Viehbacher (0.3)

Göran Stiernstedt (0.2)

Leif Vestergaard-Pedersen (0.1)

Julie Skovsby (0.0)

François Duhen (0.0)

Xavier de Villepion (0.0)

Jacques Servier (0.0)

Natascha Vlahovic (0.0)

Fabian Cancellara (0.0)

Bill Gates (0.0)

Xavier Bertrand (0.0)

Ben Bernanke (0.0)

Christine Lagarde (0.0)

François Fillon (0.0)

David Cameron (0.0)

Nicolas Sarkozy (0.0)

Help about this topicOther Names

Pfizer Inc (10)

BNP Paribas (9)

Société Générale (8)

Crédit Agricole (7)

Bourse de Paris (6)

GlaxoSmithKline (6)

Wall Street (6)

European Union (5)

European Central Bank (4)

Dow Jones (4)

Deutsche Bank (4)

Global Equities (4)

DAX 30 (3)

Exxon Mobil (3)

Volkswagen (3)

Goldman Sachs (3)

Wall Street Journal (3)

Euronext (3)

Deutsche Börse (3)

Microsoft (3)

Schering-Plough (3)

Pernod Ricard (3)

Technip (3)

European Commission (3)

EuroStoxx 50 (3)

Air France (3)

Hewlett-Packard (2)

Royal Dutch Shell (2)

Der Spiegel (2)

World Health Organization (2)

Atos Origin (2)

Novartis (2)

Merck KGaA (2)

London Stock Exchange (2)

Credit Suisse (2)

Federal Reserve System (2)

Disneyland Paris (2)

ArcelorMittal (2)

JPMorgan Chase & Co. (2)

Cisco Systems (2)

Google (2)

Siemens (2)

Groupe Danone (2)

Carrefour (2)

World Bank (2)

Boehringer Ingelheim (2)

Abbott Laboratories (2)

Alcatel (2)

Oxfam (2)

Facebook (2)

European Council (2)

Gaz de France (2)

Hugo Boss (2)

Lucent Technologies (2)

Solvay (1)

Saxo Bank (1)

Munich Re (1)

Nasdaq (1)

Bill & Melinda Gates Foundation (1)

Help about this topicRelated Stories

J&J in talks to buy Synthes for about US$20b
April 16, 2011 - April 16, 2011

Global Security Newswire: Ukraine said 'interested' in NATO missile shield role
February 25, 2011 - February 25, 2011

Help about this topicLatest Clusters - English

 [de]  [it]  [fr]  [sv]  [es]  [tr]  [bg]  [da]  [et]  [nl]  [ru]  [sl]  [ro]  [pt]

Switch in cervical cancer vaccine

bbc 24-NOV-11

Haiti Group Demands UN Pay for Cholera Outbreak

ABCnews 09-NOV-11

South Africa: People Should Not Be Dying of Rabies

allafrica 28-SEP-11

Q&A: Big pharma and the vaccine funding shortfall

guardian 06-JUN-11

J&J in talks to buy Synthes for about US$20b

channelnewsasia 16-APR-11

Sanofi-Aventis, Merck abandon deal

irishtimes 22-MAR-11

Global Security Newswire: Ukraine said 'interested' in NATO missile shield role

kyivpost 25-FEB-11

Sanofi to buy Genzyme for about $20 billion

reuters 16-FEB-11

DealBook: Finish Line Nears for Sanofi-Genzyme Talks

IHT 07-FEB-11

Epilim: Families who think epilepsy pill caused birth defects forced to drop case after legal aid withdrawn

dailymail 28-JAN-11

Govt committed to quality health care, prevention of diseases: President

Infopak 26-JAN-11

Gold, silver fall on reduced offtake at high levels

economictimes 21-DEC-10

Drug delay hits AstraZeneca stock

bbc 17-DEC-10

Weather shuts down bridge, ferries in Maritimes

CBC 06-DEC-10

Bill Gates finances Meningitis Vaccine

geotimes 05-DEC-10

Diabetes rate world's highest

peopledaily 15-NOV-10

Baghdad attack a new low in Christian onslaught in Iraq

telegraph 01-NOV-10

Baghdad church hostage drama ends

bbc 31-OCT-10

Stocks Give Up Early Gains; 3M, Apple Disappoint

CBSnews 28-OCT-10

Mexico: Copter crash kills 6 oil workers, 2 pilots

ynetnews 16-OCT-10

U.S. jobless claims jump

CBC 14-OCT-10

Sanofi makes a hostile bid for US rival Genzyme

dailymail 04-OCT-10

Lilly Tries to Reassure Hometown

IHT 18-AUG-10

Buffet's Berkshire adds Fiserv and boosts stakes in Johnson and Johnson

ChinaPost 18-AUG-10

Bank of England set to revise down growth forecast as US pledges to peg rates

dailymail 11-AUG-10

WHO chief says H1N1 flu pandemic is over (Reuters)

news 10-AUG-10

Help about this topicQuotes about - English

David Green [ said]: The QIV development program supports Sanofi Pasteur's strategy to develop new vaccine options tailored to individual segments of the population to better support health-care providers in the public health fight to reduce overall morbidity and mortality caused by influenza,

finanznachrichten 21-OCT-11

Important notice about quotes:

All quotes both by and from, are derived by an automatic algorithm with no human intervention. This means that sometimes mistakes WILL occur. Users are therefore strongly advised to check the validity of quotes from the original news report. Neither the JRC nor the European Commission accepts any responsibility for the content of these pages which are merely aggregated from open sources.
Joint Research Center

The selection and placement of stories are determined automatically by a computer program.

This site is a joint project of DG-JRC and DG-Press.

THIS SITE IS STILL WORK IN PROGRESS. THEREFORE PLEASE EXCUSE ANY PROBLEMS!

Please send any comments or suggestions to Email address as image.

This site is a project of the SES Unit of the IPSC, DG-JRC.

The information on this site is subject to a disclaimer.